Role of triamcinolone acetate in treatment of symptomatic intervertebral disc herniations via interlaminar vs transforaminal approach

D. Kumar, Dr. Mithun Shetty, Dr. Bhaskar Bhandary, Dr. Manjunath S
{"title":"Role of triamcinolone acetate in treatment of symptomatic intervertebral disc herniations via interlaminar vs transforaminal approach","authors":"D. Kumar, Dr. Mithun Shetty, Dr. Bhaskar Bhandary, Dr. Manjunath S","doi":"10.22271/ortho.2023.v9.i2d.3377","DOIUrl":null,"url":null,"abstract":"Introduction: Lowback pain is one of the most common chronic pain disorders, with 2-3% incidence of lumbar disk herniations among population. Epidural corticosteroid injections have been used since 1952 for treatment of lumbar radiculopathy with or without discogenic back pain in patient with failed medical and conservative management. Local Steroids such as triamcinolone acetate acts by limiting inflammatory response. Several approaches are available; interlaminar, transforaminal and caudal. This study was conducted to compare the efficacy of triamcinolone acetate injection by interlaminar vs transforaminal approach. AIM: To compare the efficacy of triamcinolone acetate in terms of pain relief between interlaminar approach and transforaminal approach. Methodology: In this study 60 patients with low back pain are randomly allocated to one of the two groups of 30 patients each. In both group 40mg of triamcinolone acetate solution is used. In IL approach, drug is injected blindly in the epidural space, while in TF approach drug is injected under fluoroscopic guidance using dye. Outcome consists of measuring pain relief at 2nd and 4th week after injection using Numerical Scale and Verbal Rating Scale. Data was collected after 15mins, at 2nd week and at 4th week after the injection. RESULTS : The pain relief in NRS and VAS at 2 nd week was more in patient who received triamcinolone acetate via transforaminal approach. Conclusion: Transforaminal is superior to interlaminar, as it gives target specific administration of triamcinolone acetate and is more effective than ILESI comparing the NRS and VAS score in terms of pain relief.","PeriodicalId":14302,"journal":{"name":"International Journal of Orthopaedics Sciences","volume":"29 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Orthopaedics Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22271/ortho.2023.v9.i2d.3377","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Lowback pain is one of the most common chronic pain disorders, with 2-3% incidence of lumbar disk herniations among population. Epidural corticosteroid injections have been used since 1952 for treatment of lumbar radiculopathy with or without discogenic back pain in patient with failed medical and conservative management. Local Steroids such as triamcinolone acetate acts by limiting inflammatory response. Several approaches are available; interlaminar, transforaminal and caudal. This study was conducted to compare the efficacy of triamcinolone acetate injection by interlaminar vs transforaminal approach. AIM: To compare the efficacy of triamcinolone acetate in terms of pain relief between interlaminar approach and transforaminal approach. Methodology: In this study 60 patients with low back pain are randomly allocated to one of the two groups of 30 patients each. In both group 40mg of triamcinolone acetate solution is used. In IL approach, drug is injected blindly in the epidural space, while in TF approach drug is injected under fluoroscopic guidance using dye. Outcome consists of measuring pain relief at 2nd and 4th week after injection using Numerical Scale and Verbal Rating Scale. Data was collected after 15mins, at 2nd week and at 4th week after the injection. RESULTS : The pain relief in NRS and VAS at 2 nd week was more in patient who received triamcinolone acetate via transforaminal approach. Conclusion: Transforaminal is superior to interlaminar, as it gives target specific administration of triamcinolone acetate and is more effective than ILESI comparing the NRS and VAS score in terms of pain relief.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
醋酸曲安奈酮经椎间与经椎间孔入路治疗症状性椎间盘突出症的作用
简介:腰痛是最常见的慢性疼痛疾病之一,人群中腰椎间盘突出症的发病率为2-3%。硬膜外皮质类固醇注射自1952年以来一直用于治疗伴有或不伴有椎间盘源性背痛的腰椎神经根病,这些患者的医疗和保守治疗失败。局部类固醇如醋酸曲安奈德通过限制炎症反应起作用。有几种方法可用;椎间,椎间和尾间。本研究比较醋酸曲安奈德注射液经椎间孔入路与经椎间孔入路的疗效。目的:比较醋酸曲安奈德在椎板间入路与经椎间孔入路的镇痛效果。方法:本研究将60例腰痛患者随机分为两组,每组30例。两组均使用醋酸曲安奈德溶液40mg。IL入路在硬膜外腔盲目注射药物,TF入路在透视引导下使用染料注射药物。结果包括在注射后第2周和第4周用数字量表和口头评定量表测量疼痛缓解程度。注射后15min、第2周和第4周采集数据。结果:经椎间孔入路接受醋酸曲安奈德治疗的患者第2周NRS和VAS疼痛缓解更明显。结论:经椎间孔比层间孔更能靶向给药醋酸曲安奈德,且在疼痛缓解方面比ILESI更有效,比较NRS和VAS评分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Epidemiology and treatment of Ahlback stage III to V knee osteoarthritis by total knee prostheses at Owendo University teaching hospital: About 60 cases Using subchondral one third tubular plate as a rafting plate for elevation of depressed tibial plateau fractures Functional outcome of spaghetti wrist following surgery- our experience in 26 patients Evaluation of the outcome of displaced intraarticular calcaneal fractures treated with locking plate fixation: An observational study Effectiveness of corticosteroid injection in the treatment of De Quervain`s stenosing tenosynovitis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1